Locally advanced large-cell neuroendocrine carcinoma

Clinical trials for Locally advanced large-cell neuroendocrine carcinoma explained in plain language.

Never miss a new study

Get alerted when new Locally advanced large-cell neuroendocrine carcinoma trials appear

Sign up with your email to follow new studies for Locally advanced large-cell neuroendocrine carcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

Targeted pill takes on rare skull base cancers

Disease control Recruiting now

This phase 2 trial tests enasidenib, a daily pill that targets the IDH2 gene mutation, in 40 adults with rare cancers of the nasal cavity or skull base that have spread or come back. Participants take the drug once daily in 28-day cycles, and researchers will track how long the c…

Matched conditions: LOCALLY ADVANCED LARGE-CELL NEUROENDOCRINE CARCINOMA

Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Sep 21, 2026 15:00 UTC

Locally advanced large-cell neuroendocrine carcinoma

Get alerted when new Locally advanced large-cell neuroendocrine carcinoma trials appear

Targeted pill takes on rare skull base cancers